ArticleVaccine2017

Formulation of the bivalent prostate cancer vaccine with surgifoam elicits antigen-specific effector T cells in PSA-transgenic mice.

Dev KaranPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.